Mycotoxins: risk assessment and legislation
- 1 December 1995
- journal article
- review article
- Published by Elsevier in Toxicology Letters
- Vol. 82-83, 853-859
- https://doi.org/10.1016/0378-4274(95)03599-0
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliformePublished by Elsevier ,2021
- Carcinogenic effects of low dietary levels of aflatoxin B1 in ratsPublished by Elsevier ,2002
- Liquid Chromatographic Determination of Sphmgamne and Sphingosine: Use of the Free Sphinganine-to-Sphingosine Ratio as a Biomarker for Consumption of FumonisinsJournal of AOAC INTERNATIONAL, 1994
- Toxicity and carcinogenicity of the Fusanum monilzforine metabolite, fumonisin B1, in ratsCarcinogenesis: Integrative Cancer Research, 1991
- Uncertainties in the risk assessment of three mycotoxins: aflatoxin, ochratoxin, and zearalenoneCanadian Journal of Physiology and Pharmacology, 1990
- Current situation on regulations for mycotoxins. Overview of tolerances and status of standard methods of sampling and analysisFood Additives & Contaminants, 1989
- Risk assessment of the mycotoxin zearalenoneRegulatory Toxicology and Pharmacology, 1987